FIELD: medicine.
SUBSTANCE: the present innovation deals with the method of applying compositions containing trans-clomiphen and cis-clomiphen in the ratio by weight being above or equal 71/29 for increasing the level of testosterone in blood serum in male mammalian. Application of practically pure trans-clomiphen according to the present innovation provides increased level of testosterone both at the decrease and at sufficient content of this hormone, in case of necessity or desirability of such an increase for a mammalian, at decreased number of side effects as a result of clomiphen-based therapy.
EFFECT: higher efficiency of therapy.
4 cl, 3 dwg, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TRANS-CLOMIPHENE DOSING REGIMEN | 2006 |
|
RU2413508C2 |
| METHODS AND MATERIALS WITH TRANS-CLOMIPHENE FOR TREATMENT OF MALE STERILITY | 2006 |
|
RU2404757C2 |
| TREATMENT OF HOT FLASHES AND LOSS OF BONE TISSUE CAUSED BY ANDROGEN DEPRIVATION THERAPY, USING CIS-CLOMIPHENE | 2015 |
|
RU2725086C2 |
| METHOD OF TREATING PATIENTS SUFFERING FROM CHRONIC PROSTATITIS WITH PARTIAL ANDROGEN DEFICIENCY | 2013 |
|
RU2525182C1 |
| METHOD FOR CORRECTION OF HYPERESTRADIOLEMIA AND NORMOGONADOTROPIC HYPOGONADISM IN MALES | 2010 |
|
RU2474424C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME | 2020 |
|
RU2757220C1 |
| METHOD OF TREATING HYPOGONADOTROPIC HYPOGONADISM, NASAL SPRAY AS METHOD FOR ADMINISTERING GONADORELIN ACETATE IN TREATING HYPOGONADOTROPIC HYPOGONADISM | 2019 |
|
RU2733465C1 |
| METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
| METHOD FOR TREATMENT OF ADOLESCENT HYPOGONADOTROPIC HYPOGONADISM IN EXPERIMENT | 2020 |
|
RU2750713C1 |
| PREPARATION AND METHOD FOR THE TREATMENT OF ANDROGEN DEFICIENCY IN WOMEN, ENTOMOLOGICAL CONTAINING PROTEINS | 2015 |
|
RU2577225C1 |
